Ignite Creation Date:
2024-05-06 @ 8:22 AM
Last Modification Date:
2024-10-26 @ 11:59 AM
Study NCT ID:
NCT02729961
Status:
WITHDRAWN
Last Update Posted:
2019-10-10
First Post:
2016-03-29
Brief Title:
Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma
Sponsor:
University of Washington
Organization:
University of Washington
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Systemic Anaplastic Large Cell Lymphoma |
| Anaplastic Large Cell Lymphoma ALK-Positive |
| CD30-Positive Neoplastic Cells Present |
Keywords: